Company profile

Company profileOfficial Gazette noticesJapanese original

株式会社古市富士薬品

株式会社古市富士薬品· Corporate Number: 5380002025837

This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.

Current page: Company profile

This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.

Public Record Summary

Gazette notices shown here
2
Latest public record
27 Jun 2025

Company Identity and Registry Data

English display name
株式会社古市富士薬品
Original Japanese name
株式会社古市富士薬品
Kana name
きょうえいやくひんはんばい
Corporate Number
5380002025837
Registered address
埼玉県さいたま市大宮区桜木町4丁目383番地

Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.

gBizINFO: fetched 11 Jul 2026

Corporate Number site: fetched 11 Jul 2026

Data sources

Save a record of your review

Keep the records and their sources together

Review what is included, then save the report and CSV in an evidence ZIP for internal sharing. Available source files vary by target.

This company: ¥2,980 including tax, one-time purchase. No charge for reviewing the contents. Available files are listed before checkout.

2 records on this page; confirm the delivery scope on the next page.

Four or more packs in a month? Compare Business ・ Already purchased? Sign in

Official Gazette

Japanese Official Gazette company notices

2 notice(s)

Official Gazette company notice

Official Gazette noticeCompany noticeTranslation pending
Publication / issue / page
27 Jun 2025 Extra Edition 第146号 p.94
English summary
Company notice
Published company name
株式会社古市富士薬品
Published address
さいたま市大宮区桜木町四丁目383番地
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第 38 期決算公告 / 貸借対照表の要旨(令和7年3月31日現在)
Original excerpt
第 38 期決算公告 / 貸借対照表の要旨(令和7年3月31日現在)
Show official Japanese notice text

号外第 146 号 令和7年6月27日金曜日 官 報 (号  外) 公  告 会社その他の公告page="0094"page="0094"第 38 期決算公告    令和7年6月27日さいたま市大宮区桜木町四丁目383番地株式会社古市富士薬品代表取締役 村上 隆文page="0094"貸借対照表の要旨(令和7年3月31日現在)    (単位:千円)科    目金 額 資産の部流動資産22 資産合計 22 負債及び   純資産の部 流動負債70 負債合計 70株主資本△47資本金3,500利益剰余金△3,100その他利益剰余金△3,100(うち当期純利益)(14)自己株式△446純資産合計 △47負債・純資産合計22©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Furuichi Fuji Yakuhin Co., Ltd. Financial Statements Notice for 37th Fiscal Period

Financial statements noticeFinancial report
Publication / issue / page
26 Jun 2024 Extra Edition 第153号 p.88
English summary
This is a financial statements notice for the 37th fiscal period, including a summary of the balance sheet as of March 31, 2024.
Published company name
株式会社古市富士薬品
Published address
さいたま市大宮区桜木町四丁目383番地
Translated excerpt
37th fiscal period financial statements announcement / Summary of balance sheet as of March 31, 2024
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
決算公告
Original related text
第 37 期決算公告 / 貸借対照表の要旨(令和6年3月31日現在)
Original excerpt
第 37 期決算公告 / 貸借対照表の要旨(令和6年3月31日現在)
Show official Japanese notice text

号外第 153 号 令和6年6月26日水曜日 官 報 (号  外) 公  告 会社その他の公告page="0088"page="0088"第 37 期決算公告    令和6年6月26日さいたま市大宮区桜木町四丁目383番地株式会社古市富士薬品代表取締役 村上 隆文page="0088"貸借対照表の要旨(令和6年3月31日現在)    (単位:千円)科    目金 額 資産の部流動資産92 資産合計 92 負債及び   純資産の部 流動負債154 負債合計 154株主資本△61資本金3,500利益剰余金△3,115その他利益剰余金△3,115(うち当期純損失)(70)自己株式△446純資産合計 △61負債・純資産合計92©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the editorial policy. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.